| Tablet | ||||
| Sr. No. | Generic Name | Composition | Ph. | Strength |
| 1 | Nimodipine Tablets BP | Each Film coated Tablet Contains : Nimodipine | BP | |
| Excipients | 30mg | |||
| Approved colour used. | q.s. | |||
| 2 | Furosemide Tablets USP | Each Uncoated Tablet Contains : Furosemide | USP | 40mg |
| Excipients | q.s | |||
| 3 | Montelukast Sodium Chewable Tablets USP | Each Uncoated Chewable Tablet Contains: :Montelukast sodium | ||
| Equ. to Montelukast | USP | 4mg | ||
| Excipients | q.s. | |||
| 4 | Montelukast Sodium Tablets USP | Each Film coated Tablet Contains : Montelukast Sodium | USP | |
| Equ. to Montelukast | 10mg | |||
| Excipients | q.s. | |||
| Approved colour used | ||||
| 5 | Fluconazole Tablets USP | Each Uncoated Tablet Contains: Fluconazole | USP | 150mg |
| Excipients | q.s. | |||
| Approved Colour used | ||||
| 6 | Desloratadine Tablets USP | Each film coated Tablet Contains:-Desloratadine | USP | 5mg |
| Excipients | q.s. | |||
| Approved colour used | ||||
| 7 | Terbinafine Tablets USP | Each film coated tablets contains: Terbinafine hydrochloride Equivalent to Terbinafine | USP | 250 mg . |
| Excipients | q.s. | |||
| Approved colour used | ||||
| 8 | Carbidopa and Levodopa Tablets USP | Each Uncoated Tablet Contains : Carbidopa | USP | 25mg |
| Equ. to Carbidopa Anhydrous Levodopa | ||||
| Levodopa | USP | 250mg | ||
| Excipients | q.s. | |||
| Approved colour used | ||||
| 9 | Paracetamol Tablets BP | Each uncoated tablet contains: Paracetamol | BP | 500mg |
| Excipients | q.s. | |||
| Approved colour used | ||||
| 10 | Levofloxacin Tablets | Each film coated tablet contains: Levofloxacin Hemihydrate | USP | |
| Equivalent to Levofloxacin | 250mg | |||
| Excipients | q.s. | |||
| Colour:- Approved colour used | ||||
| 11 | Levofloxacin Tablets | Each film coated tablet contains:-Levofloxacin Hemihydrate | USP | |
| Equivalent to Levofloxacin | 500 mg | |||
| Excipients | q.s. | |||
| Colour:- Approved colour used | ||||
| 12 | Dapoxetine Tablets | Each film coated tablet contains: Dapoxetine Hydrochloride | ||
| Eq. to Dapoxetine | 30mg | |||
| Excipients | q.s. | |||
| Approved colour used | ||||
| 13 | Rosuvastatin Tablets USP | Each film coated tablet contains: Rosuvastatin calcium | USP | |
| Eq.to Rosuvastatin | 10mg | |||
| Excipients | q.s. | |||
| Approved colour used | ||||
| 14 | Montelukast Sodium & Levocetirizine | Each film coated Tablet Contains :- | ||
| Dihydrochloride Tablets | Montelukast Sodium | USP | ||
| eq. to Montelukast | 10mg | |||
| Levocetirizine Dihydrochloride | USP | 5mg | ||
| Excipients | q.s. | |||
| Approved colour used | ||||
| 15 | Dexketoprofen Tablet | Each film coated Tablet Contains: Dexketoprofen trometamol | ||
| Eq. to Dexketoprofen | 12.5mg | |||
| Excipients | q.s. | |||
| Colour : Approved Coloured Used | ||||
| 16 | Dexketoprofen Tablet | Each film coated Tablet Contains: Dexketoprofen trometamol | ||
| Eq. to Dexketoprofen | 25mg | |||
| Excipients | q.s | |||
| Colour : Approved Coloured Used | ||||
| 17 | Nitrofurantoin SR Tablets | Each Film Coated Sustained Release Tablet Contains Nitrofurantoin | ||
| Excipients | USP | 100mg q.s. | ||
| Approved colour used | ||||
| 18 | Citicoline Tablets | Each Film coated Tablets Contains: Citicoline sodium | ||
| Equivalent to Citicoline Excipients | USP | |||
| Approved colour used | 500 mg q.s. | |||
| 19 | Dapoxetine Tablets | Each film coated tablet contains: Dapoxetine Hydrochloride | ||
| Eq. to Dapoxetine | ||||
| Excipients | 60mg | |||
| Approved colour used | q.s. | |||
| 20 | Leflunomide Tablets USP | Each film coated Tablet Contains: Leflunomide | ||
| Excipients | USP | 20mg q.s | ||
| Approved Coloured Used | ||||
| 21 | Cholecalciferol | Each uncoated chewable tablet contains Cholecalciferol (Stabilized) | ||
| Tablet USP | Excipients | USP | 60000IU | |
| Approved colour used | q.s. | |||
| 22 | Aciclovir Dispersible Tablet BP | Each uncoated tablet contains: Aciclovir | ||
| Excipients | BP | 800 mg | ||
| Approved colour used | ||||
| 23 | Pantoprazole Sodium Delayed-Release Tablets USP | Each enteric coated tablet contains:- Pantoprazole Sodium | ||
| Eq. to Pantoprazole Excipients | USP | 40 mg | ||
| Approved colour used | q.s. | |||
| 24 | Digoxin Tablets USP | Each uncoated Tablet Contains : Digoxin | ||
| Excipients | USP | 0.25mg q.s. | ||
| Approved colour used | ||||
| 25 | Etoricoxib & Thiocolchicoside Tablets | Each film coated tablet Contains :- Etoricoxib | 60mg 4mg q.s | |
| Thiocolchicoside | ||||
| Excipients | ||||
| Approved colour used | ||||
| 26 | Ebastine Tablets | Each film coated tablet contains: Ebastine | ||
| Excipients | BP | 10mg q.s | ||
| Approved colour used | ||||
| 27 | Ebastine Tablets | Each film coated tablet contains: Ebastine | 20mg | |
| Excipients | BP | q.s | ||
| Approved colour used | ||||
| 28 | Biotin Tablets USP | Each Film coated Tablet Contains : Biotin | 10mg | |
| Excipients | USP | q.s. | ||
| Approved colour used | ||||
| 29 | Chlorpheniramine Maleate Tablets USP | Each Uncoated Tablet Contains : Chlorpheniramine Maleate Excipients | ||
| USP | 4mg q.s. | |||
| 30 | Haloperidol Tablet USP | Each Uncoated Tablet Contains : Haloperidol | ||
| Excipients | USP | 5mg q.s. | ||
| 31 | Chlorpromazine Hydrochloride Tablets USP | Each film coated Tablet Contains : Chlorpromazine Hydrochloride Excipients | ||
| Approved colour used. | USP | 50mg q.s. | ||
| 32 | Pyridoxine Hydrochloride Tablets USP | Each uncoated Tablet Contains : Pyridoxine Hydrochloride Excipients | ||
| USP | 50mg q.s. | |||
| 33 | Carbimazole Tablets BP | Each Film coated Tablet Contains : Carbimazole | ||
| Excipients | BP | 5mg q.s. | ||
| Approved colour used | ||||
| 34 | Hydrochlorothiazide Tablets USP | Each uncoated Tablet Contains : Hydrochlorothiazide | ||
| Excipients | USP | 25mg q.s. | ||
| Approved colour used. | ||||
| 35 | Hydrochlorothiazide Tablets USP | Each uncoated Tablet Contains : Hydrochlorothiazide | ||
| Excipients | USP | 50mg q.s. | ||
| Approved colour used. | ||||
| 36 | Propranolol Hydrochloride Tablets USP | Each Uncoated Tablet Contains: Propranolol Hydrochloride | ||
| Excipients | USP | 10mg | ||
| Approved colour used. | q.s. | |||
| 37 | Ibuprofen Tablets USP | Each Film coated Tablet Contains : Ibuprofen | ||
| Excipients | USP | 200mg | ||
| Approved colour used | q.s. | |||
| 38 | Ibuprofen Tablets USP | Each Film coated Tablet Contains : Ibuprofen | ||
| Excipients | USP | 400mg | ||
| Approved colour used | q.s. | |||
| 39 | Ciprofloxacin Tablets USP | Each film coated Tablet Contains:- Ciprofloxacin Hydrochloride | ||
| Eq. to Ciprofloxacin | USP | |||
| Excipients | 500mg q.s. | |||
| Approved colour used | ||||
| 40 | Atenolol Tablets USP | Each uncoated Tablet Contains : Atenolol | ||
| Excipients | USP | 50mg q.s. | ||
| Approved colour used. | ||||
| 41 | Atenolol Tablets USP | Each uncoated Tablet Contains : Atenolol | ||
| Excipients | USP | 100mg q.s. | ||
| Approved colour used. | ||||
| 42 | Lisinopril Tablets USP | Each uncoated tablet contains: Lisinopril | ||
| Eq. to anhydrous Lisinopril | USP | |||
| Excipients | 10mg q.s. | |||
| Approved colour used | ||||
| 43 | Lisinopril Tablets USP | Each uncoated tablet contains: Lisinopril | ||
| Eq. to anhydrous Lisinopril | USP | |||
| Excipients | 20mg q.s. | |||
| Approved colour used | ||||
| 44 | Ibuprofen and Paracetamol Tablets | Each uncoated tablet contains : Ibuprofen | ||
| Paracetamol | BP | 400mg | ||
| Excipients | BP | 325mg q.s. | ||
| Approved colour used. | ||||
| 45 | Salbutamol Tablets BP | Each uncoated tablet contains: Salbutamol Sulfate | ||
| Eq. to Salbutamol | BP | 2mg | ||
| Excipients | q.s. | |||
| Approved colour used. | ||||
| 46 | Salbutamol Tablets BP | Each uncoated tablet contains: Salbutamol Sulfate | ||
| Eq. to Salbutamol | BP | 4mg | ||
| Excipients | q.s. | |||
| Approved colour used. | ||||
| 47 | Atorvastatin Calcium Tablets USP | Each film coated tablet contains: Atorvastatin Calcium | ||
| Eq. to Atorvastatin Calcium | USP | |||
| Excipients | 10mg q.s. | |||
| Approved colour used. | ||||
| 48 | Atorvastatin Calcium Tablets USP | Each film coated tablet contains: Atorvastatin Calcium | ||
| Eq. to Atorvastatin Calcium | USP | |||
| Excipients | 20mg q.s. | |||
| Approved colour used. | ||||
| 49 | Atorvastatin Calcium Tablets USP | Each film coated tablet contains: Atorvastatin Calcium | ||
| Eq. to Atorvastatin Calcium | USP | |||
| Excipients | 40mg q.s. | |||
| Approved colour used. | ||||
| 50 | Cetirizine Hydrochloride Tablets USP | Each film coated tablet contains: | ||
| Cetirizine Hydrochloride | USP | 10mg | ||
| Excipients | q.s. | |||
| Approved colour used. | ||||
| 51 | Metformin Hydrochloride Tablets USP | Each film coated tablet contains: | ||
| Metformin Hydrochloride | USP | 500mg | ||
| Excipients | q.s. | |||
| Approved colour used. | ||||
| 52 | Ofloxacin Tablets USP | Each film coated tablet contains: | ||
| Ofloxacin | USP | 200mg | ||
| Excipients | q.s. | |||
| Approved colour used. | ||||
| 53 | Ofloxacin Tablets USP | Each film coated tablet contains: | ||
| Ofloxacin | USP | 400mg | ||
| Excipients | q.s. | |||
| Approved colour used. | ||||
| 54 | Rosuvastatin Tablets USP | Each film coated tablet contains: Rosuvastatin Calcium | ||
| Eq. to Rosuvastatin | USP | |||
| Excipients | 5mg | |||
| Approved colour used. | q.s. | |||
| 55 | Rosuvastatin Tablets USP | Each film coated tablet contains: Rosuvastatin Calcium | ||
| Eq. to Rosuvastatin | USP | |||
| Excipients | 20mg | |||
| Approved colour used. | q.s. | |||
| 56 | Enalapril Maleate Tablets | Each uncoated tablet contains: Enalapril Maleate | ||
| USP | Excipients | USP | 5mg | |
| Approved colour used. | q.s. | |||
| 57 | Enalapril Maleate Tablets USP | Each uncoated tablet contains: Enalapril Maleate | ||
| Excipients | USP | 10mg | ||
| Approved colour used. | q.s. | |||
| 58 | Enalapril Maleate Tablets USP | Each uncoated tablet contains: Enalapril Maleate | ||
| Excipients | USP | 20mg | ||
| Approved colour used. | q.s. | |||
| 59 | Losartan Potassium Tablets USP | Each film coated tablet contains: Losartan Potassium | ||
| Excipients | USP | 50mg | ||
| Approved colour used. | q.s. | |||
| 60 | Losartan Potassium Tablets USP | Each film coated tablet contains: Losartan Potassium | ||
| Excipients | USP | 100mg | ||
| Approved colour used. | q.s. | |||
| 61 | Losartan Potassium and Hydrochlorothiazide Tablets USP | Each film coated tablet contains: Losartan Potassium | ||
| Hydrochlorothiazide | USP | 50mg | ||
| Excipients | USP | 12.5mg | ||
| Approved colour used. | q.s. | |||
| 62 | Telmisartan Tablets USP | Each uncoated tablet contains: Telmisartan | ||
| Excipients | USP | 80mg | ||
| Approved colour used. | q.s. | |||
| 63 | Amlodipine Besylate Tablets USP | Each uncoated tablet contains: Amlodipine Besylate | ||
| Eq. to Amlodipine | USP | |||
| Excipients | 5mg | |||
| Approved colour used. | q.s. | |||
| 64 | Amlodipine Besylate Tablets USP | Each uncoated tablet contains: Amlodipine Besylate | ||
| Eq. to Amlodipine | USP | |||
| Excipients | 10mg | |||
| Approved colour used. | q.s. | |||
| 65 | Nifedipine Prolonged-release Tablets BP | Each film coated prolonged-release tablet contains: Nifedipine | ||
| Excipients | BP | 20mg | ||
| Approved colour used. | q.s. | |||
| 66 | Ferrous Sulfate Tablets USP | Each film coated tablet contains: Ferrous Sulfate Heptahydrate | ||
| Excipients | USP | 200mg | ||
| Approved colour used. | q.s. | |||
| Capsule | ||||
| 1 | Doxycycline Hyclate Capsules USP | Each hard gelatin capsule contains : Doxycycline Hyclate | ||
| Equ. to Doxycycline Excipients | USP | 100mg | ||
| Approved colour used in empty capsule shells. | q.s. | |||
| 2 | Pregabalin Capsules | Each Hard Gelatin Capsule contains: Pregabalin | USP | 75mg |
| Excipients | q.s | |||
| Approved colour used in Empty Hard Gelatin Capsule | ||||
| 3 | Pregabalin Capsules | Each Hard Gelatin Capsule contains: Pregabalin | USP | 150mg |
| Excipients | q.s | |||
| Approved colour used in Empty Hard Gelatin Capsule | ||||
| 4 | Dexlansoprazole Modified Release Capsule | Each Hard Gelatin Capsules Contains : | ||
| Dexlansoprazole | 60mg | |||
| (as Modified Release Pellets) | ||||
| Approved colour used in Pellets & Empty Capsule Shells. | ||||
| Cream Ointment & Gel | ||||
| 1 | Diclofenac | Composition: | ||
| Diethyl amine, | Diclofenac Diethyl amine | BP | 1.16%w/w | |
| methyl Salicylate, linseed Oil & Menthol Gel | Equ. to Diclofenac Sodium 1.0%w/w) | |||
| Linseed Oil | BP | 3.0%w/w | ||
| Methyl Salicylate | BP | 10.0%w/w | ||
| Menthol | BP | 5.0%w/w | ||
| Benzyl Alcohol | BP | 1.0%w/w | ||
| (as preservative) | q.s. | |||
| Gel Base | ||||
| 2 | Mupirocin ointment USP | Mupirocin Topical | USP | 2.0%w/w |
| Ointment Base | q.s. | |||
| Liquids | ||||
| Sr. No. | Generic Name | Composition | Ph. | Strength |
| 1 | Azithromycin Oral Suspension | Each 5 ml contains: | ||
| Azithromycin Dihydrate | USP | |||
| eq. to Anhydrous Azithromycin | 200mg | |||
| In a flavoured Syrupy base. | q.s. | |||
| Approved Colour Used. | ||||
| 2 | Zinc Sulfate Oral Solution | Each 5 ml of contains: | ||
| USP | Zinc Sulfate monohydrate | USP | ||
| Eq. to elemental Zinc | 10mg | |||
| Excipients | q.s. | |||
| Approved colour used | ||||
| 3 | Salbutamol Suspension BP | Each 5 ml contains : | ||
| Salbutamol Sulfate | BP | 2mg | ||
| Eq. to Salbutamol | ||||
| In Flavoured Syrupy base | q.s. | |||
| Approved colour used. | ||||
| 4 | Co-trimoxazole Oral Suspension BP | Each 5 ml contains : Trimethoprim | ||
| Sulfamethoxazole | BP | 40mg | ||
| In Flavoured Syrupy base | BP | 200mg | ||
| Approved colour used. | q.s. | |||
| 5 | Erythromycin Estolate Oral Suspension USP | Each 5 ml contains : | ||
| Erythromycin Estolate | USP | |||
| Eq. to Erythromycin base | 125mg | |||
| In Flavoured Syrupy base | q.s. | |||
| Approved colour used. | ||||
| 6 | Ciprofloxacin for Oral Suspension USP | Each 5 ml contains : | ||
| Ciprofloxacin Hydrochloride | USP | |||
| Eq. to Ciprofloxacin | 250mg | |||
| In Flavoured Syrupy base | q.s. | |||
| Approved colour used. | ||||